BLOQMUT Trademark

Trademark Overview


On Wednesday, March 10, 2021, a trademark application was filed for BLOQMUT with the United States Patent and Trademark Office. The USPTO has given the BLOQMUT trademark a serial number of 90571091. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The BLOQMUT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; Pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; Pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevent...
bloqmut

General Information


Serial Number90571091
Word MarkBLOQMUT
Filing DateWednesday, March 10, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; Pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; Pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; Pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIngelheim 55218
DE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIngelheim 55218
DE

Trademark Events


Event DateEvent Description
Saturday, March 13, 2021NEW APPLICATION ENTERED
Thursday, June 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 16, 2021ASSIGNED TO EXAMINER
Thursday, September 23, 2021NON-FINAL ACTION WRITTEN
Thursday, September 23, 2021NON-FINAL ACTION E-MAILED
Thursday, September 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 21, 2022ASSIGNED TO EXAMINER
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022SOU EXTENSION 1 FILED
Tuesday, May 24, 2022SOU EXTENSION 1 GRANTED
Tuesday, May 24, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 28, 2023SOU EXTENSION 3 GRANTED
Thursday, May 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 14, 2023SOU EXTENSION 2 FILED
Friday, April 14, 2023SOU EXTENSION 2 GRANTED
Tuesday, April 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 28, 2023SOU EXTENSION 3 FILED
Saturday, September 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED